Literature DB >> 16441826

Protecting the endothelium: a new focus for management of chronic kidney disease.

Jose A Diaz-Buxo1, H Feidhlim Woods.   

Abstract

It is being increasingly recognized that cardiovascular disease (CVD) and its complications are the most important cause of morbidity and mortality in patients with chronic kidney disease (CKD) and dialysis patients. If outcomes for these patients are to be improved, therapeutic strategies at all stages of CKD will have to target the etiologies and mechanisms that lead to CVD. In this review, we focus on the central role of endothelial dysfunction as the critical precursor of CVD. We argue that a better understanding of endothelial dysfunction by nephrologists and dialysis physicians is necessary if there is to be success in limiting the CVD epidemic that kills and maims our patients. The extensive studies to explain the high prevalence of vascular disease in patients with CKD have shown the close relationship among endothelial dysfunction, inflammation, and atherosclerosis. The pathogenesis starts with endothelial cell injury from any of many possible causes, and strategies to reduce the burden of CVD in uremic and dialysis patients must be directed at restoring normal endothelial function or, at the least, preventing aggravation of endothelial damage. At the center of the exploration of endothelial dysfunction and atherosclerosis are oxidative stress and inflammation. Of these, which is the chicken and which is the egg is unknown, but in the setting of uremia, endothelial injury because of free radical, oxidative stress is likely to precede inflammation. The issues raised here are highly complex and most renal practitioners may not have been adequately exposed to the background research underlying current thinking of the pathogenesis of vascular disease. Clearly, progress in management of CVD in patients with CKD will require collaboration with experts in the research and treatment of vascular disease. Nephrologists seeking optimum outcomes for patients with CKD will need to become "endotheliologists" or, at the least, subscribe to a mission "to protect the endothelium."

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16441826     DOI: 10.1111/j.1542-4758.2006.01173.x

Source DB:  PubMed          Journal:  Hemodial Int        ISSN: 1492-7535            Impact factor:   1.812


  9 in total

1.  Changes in arterial stiffness following dialysis in relation to overhydration and to endothelial function.

Authors:  Simona Hogas; Serban Ardeleanu; Liviu Segall; Dragomir Nicolae Serban; Ionela Lacramioara Serban; Mihai Hogas; Mugurel Apetrii; Mihai Onofriescu; Radu Sascau; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2011-03-19       Impact factor: 2.370

2.  High soluble vascular cell adhesion molecule-1 concentrations predict long-term mortality in hemodialysis patients.

Authors:  Jia-Feng Chang; Shih-Ping Hsu; Mei-Fen Pai; Ju-Yeh Yang; Hung-Yuan Chen; Hon-Yen Wu; Yu-Sen Peng
Journal:  Int Urol Nephrol       Date:  2013-04-06       Impact factor: 2.370

3.  Asymmetric dimethylarginine and whole blood viscosity in renal failure.

Authors:  Mary S Hammes; Sydeaka Watson; Frederic L Coe; Faris Ahmed; Emily Beltran; Promila Dhar
Journal:  Clin Hemorheol Microcirc       Date:  2015       Impact factor: 2.375

Review 4.  The scientific principles and technological determinants of haemodialysis membranes.

Authors:  Sudhir K Bowry; Charles Chazot
Journal:  Clin Kidney J       Date:  2021-12-27

5.  The Increase in Circulating Levels of Pro-Inflammatory Chemokines, Cytokines, and Complement C5 in Canines with Impaired Kidney Function.

Authors:  Selena K Tavener; Dennis E Jewell; Kiran S Panickar
Journal:  Curr Issues Mol Biol       Date:  2022-04-11       Impact factor: 2.976

6.  Vascular damage in kidney disease: beyond hypertension.

Authors:  Andréa E M Stinghen; Roberto Pecoits-Filho
Journal:  Int J Hypertens       Date:  2011-08-14       Impact factor: 2.420

7.  Effect of PKC-β Signaling Pathway on Expression of MCP-1 and VCAM-1 in Different Cell Models in Response to Advanced Glycation End Products (AGEs).

Authors:  Lisienny C T Rempel; Alessandra B Finco; Rayana A P Maciel; Bruna Bosquetti; Larissa M Alvarenga; Wesley M Souza; Roberto Pecoits-Filho; Andréa E M Stinghen
Journal:  Toxins (Basel)       Date:  2015-05-14       Impact factor: 4.546

Review 8.  Clinical relevance of abstruse transport phenomena in haemodialysis.

Authors:  Sudhir K Bowry; Fatih Kircelli; Mooppil Nandakumar; Tushar J Vachharajani
Journal:  Clin Kidney J       Date:  2021-12-27

Review 9.  Blood-incompatibility in haemodialysis: alleviating inflammation and effects of coagulation.

Authors:  Sudhir K Bowry; Fatih Kircelli; Rainer Himmele; Sagar U Nigwekar
Journal:  Clin Kidney J       Date:  2021-12-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.